Breast Cancer Liquid Biopsy Market (By Circulating Biomarkers: Circulating Tumor Cells, Circulating Cell-free DNA; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Published Date : Sep 2022 | No. of Pages : 150+ Pages | Category : Healthcare

The global breast cancer liquid biopsy market was estimated at USD 87.71 million in 2021 and it is expected to surpass around USD 368.75 million by 2030, poised to grow at a CAGR of 17.3% from 2022 to 2030.

Breast Cancer Liquid Biopsy Market Size 2021 to 2030

Breast cancer liquid biopsy market is growing as a result of the increasing prevalence of breast cancer among the population, growing awareness about early diagnosis, and treatment along with a rising preference for non-invasive procedures. For instance, according to WHO, in 2020, 2.3 million women were diagnosed with breast cancer which resulted in the death of 685,000 women globally. Moreover, liquid biopsy are been proposed as a novel method for early detection of breast cancer which further increases its adoption further propelling the growth.

Technological advancements in ongoing research on circulating biomarkers have led to the development of a lesser invasive method of detecting non-hematological cancers. Liquid biopsy is considered viable for real-time monitoring of patients in comparison with conventional tumor biopsy. Owing to continuous advancements in related areas, awareness about the clinical importance of liquid biopsy is growing. To make these technologies globally available, further interventional clinical trials are needed, along with the development of an algorithm to combine proper circulating biomarkers. Several companies are undertaking initiatives to boost the global adoption of biopsies which is contributing to growth. As per John Hopkins Medicine in June 2022, liquid biopsy can be used to detect advanced breast cancer biomarkers in 5 hours, commercialization of such tests in the upcoming years is projected to make the diagnosis of the condition easier.

North America dominated the overall market in 2021 which can be attributed to high disease prevalence, rapid technological advancements, and growing government initiatives for cancer diagnosis. The U.S. is the biggest market for liquid biopsy tests owing to a high prevalence rate of the condition in the country, there is significant usage of oncology diagnostic tests. Moreover, rapid technological advancements and recent FDA approvals for liquid biopsy tests coupled with intense competition between biotechnology companies are among the factors expected to boost market growth over the forecast period. Furthermore, major players operating in the region are focusing on collaboration and expansion to meet the escalating demand. For instance, in August 2022, Guardant and Merck KGaA collaborated to expand their precision therapeutics and focus on hard-to-treat cancer.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 87.71 million  
Revenue Forecast by 2030 USD 368.75 million 
Growth rate from 2022 to 2030 CAGR of 17.3%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Circulating Biomarkers, Application
Companies Covered

Biocept, Inc., Fluxion Biosciences, Inc., F. Hoffmann-La Roche Ltd., Sysmex Corporation, Thermo Fisher Scientific Inc. Menarini Group, NeoGenomics Laboratories, Inc., Qiagen N.V., and Myriad Genetics, I

 

Key Players

  • Biocept, Inc.
  • Fluxion Biosciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc. Menarini Group 
  • NeoGenomics Laboratories, Inc.
  • Qiagen N.V.
  • Myriad Genetics, Inc.

Market Segmentation

  • By Circulating Biomarkers
    • Circulating Tumor Cells
    • Circulating Cell-free DNA
    • Extracellular Vesicles
    • Other Circulating Biomarkers
  • By Application
    • Targeting Treatment
    • Companion Diagnostics
    • Molecular
    • Others

Featured Research Reports

  • Featured Research Reports

    Neuro-navigation Systems Market (By Product Type: Optical System, Electromagnetic System; By Application; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Forensic Genomics Market (By Solution: Kits, Analyzers & Sequencers, Software, Consumables; By Method; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Personalized Medicine Biomarkers Market (By Technology: Liquid Biopsy; By Application: Oncology, Cardiology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    3D Printed Prosthetics Market (By Product Type: Sockets, Limbs, Joints, Covers; By Material; By End-Use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Vulvovaginal Candidiasis Treatment Market (By Drug Type: Clotrimazole, Nystatin, Fluconazole; By Route Of Administration; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...